美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再生元製藥公司

737.71

-19.0200-2.51%

盤後：733.33-4.3800-0.59%17:07 EDT

成交量：49.21萬

成交額：3.65億

市值：779.91億

市盈率：17.74

高：759.47

開：756.65

低：736.64

收：756.73

52周最高：821.11

52周最低：476.49

股本：1.06億

流通股本：1.03億

量比：0.71

換手率：0.48%

股息：3.61

股息率：0.49%

每股收益(TTM):41.59

每股收益(LYR):41.48

淨資產收益率：14.87%

總資產收益率：5.91%

市淨率：2.50

市盈率(LYR):17.78

資料載入中...

總覽公司新聞資訊公告

阿斯利康藥物在後期試驗中減少慢性肺病復發

Dupixent®（Dupilumab）獲日本批准，成為首個治療成人天皰瘡（BP）的靶向藥物

Kali Therapeutics 與賽諾菲簽約開發自身免疫療法

EyePoint 起訴競爭對手 Ocular Therapeutix，稱其虛假宣傳眼科藥物

FDA確認2025年11月19日獲批的Eylea Hd補充申請符合優先審評券兑換標準

FDA批准Eylea Hd治療罕見兒科疾病兑現優先審評券

FDA 連發多份 CRL，開年大批新藥上市申請已遭拒

BUZZ-Regeneron 公布減肥藥試驗數據利好後股價上漲

再生元授權肥胖治療藥物Olatorepatide在中國患者中展現積極三期臨床結果

再生元製藥公司：Olatorepatide治療患者在48周內實現高達19%的體重減輕

再生元製藥公司計劃今年晚些時候啓動Olatorepatide全球三期註冊項目

再生元製藥公司：Olatorepatide展現良好胃腸道耐受性，不良事件發生率更低

再生元高管預期將肥胖症藥物定價合理貼近無降膽固醇功效療法水平——TD Cowen會議透露

再生元製藥公司獲CHMP建議：擴展Dupixent適用年齡至2-11歲中重度CSU患兒

歐盟建議批准Dupixent®（度普利尤單抗）用於治療持續性症狀的幼童慢性自發性蕁麻疹

歐盟CHMP建議擴大Dupixent（Dupilumab）適用範圍：用於治療2至11歲兒童慢性自發性蕁麻疹

賽諾菲新適應症獲批鼻科疾病版圖再拓展：新增過敏性真菌性鼻竇炎與伴鼻息肉慢性鼻竇炎形成互補

賽諾菲與再生元Dupixent獲美國FDA批准成為首個且唯一用於過敏性真菌性鼻竇炎藥物

再生元製藥garetosmab生物製劑許可申請獲FDA優先審評資格

再生元Garetosmab生物製劑許可申請獲FDA優先審評資格用於治療進行性骨化性纖維發育不良(FOP)

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/REGN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"再生元製藥公司","latestPrice":737.71,"timestamp":1774641600000,"preClose":756.73,"halted":0,"volume":492129,"hourTrading":{"tag":"盘后","latestPrice":733.33,"preClose":737.71,"latestTime":"17:07 EDT","volume":26662,"amount":19669202.6204,"timestamp":1774645652060,"change":-4.38,"changeRate":-0.005937,"amplitude":0.007971},"delay":0,"changeRate":-0.025134460111268197,"floatShares":103302739,"shares":105719806,"eps":41.59414,"marketStatus":"盤後交易","change":-19.02,"latestTime":"03-27 17:13:36 EDT","open":756.65,"high":759.4665,"low":736.64,"amount":365496432.6618,"amplitude":0.030165,"askPrice":752.1,"askSize":2,"bidPrice":733.11,"bidSize":2,"shortable":3,"etf":0,"ttmEps":41.59414,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774656000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":756.73,"dividendRate":0.0049,"preHourTrading":{"tag":"盘前","latestPrice":757,"preClose":756.73,"latestTime":"09:28 EDT","volume":287,"amount":216387.0079,"timestamp":1774618081013,"change":0.27,"changeRate":0.000357,"amplitude":0.009515},"postHourTrading":{"tag":"盘后","latestPrice":733.33,"preClose":737.71,"latestTime":"17:07 EDT","volume":26662,"amount":19669202.6204,"timestamp":1774645652060,"change":-4.38,"changeRate":-0.005937,"amplitude":0.007971},"volumeRatio":0.714144,"impliedVol":0.4377,"impliedVolPercentile":0.8167},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":103302739,"roa":"5.91%","roe":"14.87%","lyrEps":41.48,"volumeRatio":0.714144,"shares":105719806,"dividePrice":3.614679,"high":759.4665,"amplitude":0.030165,"preClose":756.73,"low":736.64,"week52Low":476.4869,"pbRate":"2.50","psRate":"5.44","week52High":821.11,"institutionHeld":0.8514,"latestPrice":737.71,"eps":41.59414,"divideRate":0.0049,"volume":492129,"delay":0,"ttmEps":41.59414,"open":756.65,"prevYearClose":771.87,"prevWeekClose":732.87,"prevMonthClose":781.67,"prevQuarterClose":771.87,"fiveDayClose":732.87,"twentyDayClose":781.67,"sixtyDayClose":773.94,"dividendPayoutRate":0.08173144917266295,"dividendFrequency":"Q","dividendGrowthYears":0,"fiveYearAvgDividendRate":0.004548156187818177},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"REGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777449600000,"name":null,"time":"盤前","dateTimestamp":1777435200000,"actualEps":null},{"date":"2026-02-20","symbol":"REGN","amount":0.94,"announcedDate":"2026-01-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-05","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-05"},{"market":"US","date":"2026-01-30","symbol":"REGN","fiscalQuarterEnding":"2025/12","expectedEps":8.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1769749200000,"reportTimeType":"pre","actualEps":9.9},{"date":"2025-11-20","symbol":"REGN","amount":0.88,"announcedDate":"2025-10-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-20","defaultRemindTime":1763649000000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-05","payableDate":"2025-11-20","currency":"USD","dateTimestamp":1763614800000,"payDate":"2025-12-05"},{"market":"US","date":"2025-10-28","symbol":"REGN","fiscalQuarterEnding":"2025/09","expectedEps":7.52,"name":null,"time":"盤前","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":9.63}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"},{"executeDate":"2025-05-20","recordDate":"2025-05-20","paymentDate":"2025-06-06","value":0.88,"currency":"USD"},{"executeDate":"2025-08-18","recordDate":"2025-08-18","paymentDate":"2025-09-03","value":0.88,"currency":"USD"},{"executeDate":"2025-11-20","recordDate":"2025-11-20","paymentDate":"2025-12-05","value":0.88,"currency":"USD"},{"executeDate":"2026-02-20","recordDate":"2026-02-20","paymentDate":"2026-03-05","value":0.94,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2903,"buy":0.4839,"hold":0.2258,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4839,"analysts":31,"updateTime":1774497600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2026-03-26","current":18.193188,"percent":0.592352,"low":7.447139,"twenty":11.200433,"median":15.166431,"eighty":20.54891,"high":30.763504,"avg":16.433517,"sd":5.732006,"marketCap":76910466002},"quantilePoints":[{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816},{"date":"2025-04-11","current":13.252327,"twenty":11.205984,"median":17.191443,"eighty":24.571362,"marketCap":58477215997},{"date":"2025-04-17","current":13.322422,"twenty":11.205984,"median":17.137002,"eighty":24.420237,"marketCap":58786517328},{"date":"2025-04-25","current":14.54678,"twenty":11.205526,"median":16.999149,"eighty":24.304801,"marketCap":64189123276},{"date":"2025-05-02","current":13.856076,"twenty":11.205526,"median":16.947475,"eighty":24.14557,"marketCap":62342643230},{"date":"2025-05-09","current":12.861961,"twenty":11.205526,"median":16.904119,"eighty":24.034457,"marketCap":57869822741},{"date":"2025-05-16","current":13.738417,"twenty":11.205526,"median":16.818894,"eighty":23.30219,"marketCap":61813259090},{"date":"2025-05-23","current":14.016947,"twenty":11.205526,"median":16.720573,"eighty":23.015778,"marketCap":63066451884},{"date":"2025-05-30","current":14.217508,"twenty":11.205526,"median":16.67877,"eighty":22.627279,"marketCap":63968835228},{"date":"2025-06-06","current":11.344838,"twenty":11.205526,"median":16.611067,"eighty":22.386399,"marketCap":51043831635},{"date":"2025-06-13","current":12.255347,"twenty":11.205526,"median":16.566176,"eighty":22.027357,"marketCap":55140482954},{"date":"2025-06-20","current":12.061362,"twenty":11.200433,"median":16.515091,"eighty":21.897066,"marketCap":54267685949},{"date":"2025-06-27","current":12.23562,"twenty":11.200433,"median":16.466434,"eighty":21.777356,"marketCap":55051723937},{"date":"2025-07-03","current":12.854681,"twenty":11.200433,"median":16.436479,"eighty":21.694973,"marketCap":57837066437},{"date":"2025-07-11","current":13.145893,"twenty":11.200433,"median":16.352502,"eighty":21.545896,"marketCap":59147318600},{"date":"2025-07-18","current":12.916681,"twenty":11.200433,"median":16.266005,"eighty":21.394057,"marketCap":58116023350},{"date":"2025-07-25","current":13.2605,"twenty":11.200433,"median":16.171129,"eighty":21.327342,"marketCap":59662966226},{"date":"2025-08-01","current":12.570256,"twenty":11.200433,"median":16.134227,"eighty":21.266838,"marketCap":56557352113},{"date":"2025-08-08","current":13.018488,"twenty":11.200433,"median":16.064063,"eighty":21.218674,"marketCap":58044230031},{"date":"2025-08-15","current":13.161975,"twenty":11.200433,"median":16.006911,"eighty":21.149835,"marketCap":58683981548},{"date":"2025-08-22","current":13.910573,"twenty":11.200433,"median":15.875495,"eighty":20.876399,"marketCap":62021680306},{"date":"2025-08-29","current":13.479181,"twenty":11.200433,"median":15.719991,"eighty":20.710997,"marketCap":60098278257},{"date":"2025-09-05","current":13.191044,"twenty":11.195339,"median":15.458743,"eighty":20.662336,"marketCap":58813590851},{"date":"2025-09-12","current":13.213835,"twenty":11.200433,"median":15.311559,"eighty":20.660944,"marketCap":58915204544},{"date":"2025-09-19","current":13.923363,"twenty":11.200433,"median":15.184019,"eighty":20.660944,"marketCap":62078708399},{"date":"2025-09-26","current":12.918721,"twenty":11.200433,"median":15.159837,"eighty":20.660944,"marketCap":57599410905},{"date":"2025-10-03","current":13.953363,"twenty":11.200433,"median":15.09039,"eighty":20.660944,"marketCap":62212465200},{"date":"2025-10-10","current":13.253369,"twenty":11.200433,"median":15.044221,"eighty":20.620124,"marketCap":59091473195},{"date":"2025-10-17","current":13.236393,"twenty":11.200433,"median":15.012864,"eighty":20.570237,"marketCap":59015781363},{"date":"2025-10-24","current":13.388019,"twenty":11.200433,"median":14.951173,"eighty":20.570237,"marketCap":59691823484},{"date":"2025-10-31","current":14.657963,"twenty":11.200433,"median":14.925633,"eighty":20.56799,"marketCap":67104153434},{"date":"2025-11-07","current":14.497273,"twenty":11.200433,"median":14.884486,"eighty":20.54891,"marketCap":66368515277},{"date":"2025-11-14","current":15.57571,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":71305601485},{"date":"2025-11-21","current":16.517214,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":75615804968},{"date":"2025-11-28","current":17.491886,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":80077855657},{"date":"2025-12-05","current":16.198972,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":74158892579},{"date":"2025-12-12","current":16.736846,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":76621279715},{"date":"2025-12-19","current":16.779652,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":76817244691},{"date":"2025-12-26","current":17.564051,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":80408225931},{"date":"2026-01-02","current":17.2987,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":79193448277},{"date":"2026-01-09","current":17.951769,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":82183196658},{"date":"2026-01-16","current":16.627478,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":76120594330},{"date":"2026-01-23","current":16.932049,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":77514921046},{"date":"2026-01-30","current":16.796012,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":76892142300},{"date":"2026-02-06","current":17.463522,"twenty":11.200433,"median":14.866218,"eighty":20.54891,"marketCap":78671421873},{"date":"2026-02-13","current":17.851231,"twenty":11.200433,"median":14.916234,"eighty":20.54891,"marketCap":80418010971},{"date":"2026-02-20","current":17.822301,"twenty":11.200433,"median":14.936818,"eighty":20.54891,"marketCap":80287683818},{"date":"2026-02-27","current":17.558285,"twenty":11.200433,"median":14.959672,"eighty":20.54891,"marketCap":79098320266},{"date":"2026-03-06","current":17.424797,"twenty":11.200433,"median":15.026763,"eighty":20.54891,"marketCap":78496968203},{"date":"2026-03-13","current":17.007475,"twenty":11.200433,"median":15.083229,"eighty":20.54891,"marketCap":76616973357},{"date":"2026-03-20","current":16.798814,"twenty":11.200433,"median":15.127154,"eighty":20.54891,"marketCap":75676975934},{"date":"2026-03-26","current":17.072624,"twenty":11.200433,"median":15.166431,"eighty":20.54891,"marketCap":76910466002}],"updateTime":1774607581304},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622273158","title":"阿斯利康藥物在後期試驗中減少慢性肺病復發","url":"https://stock-news.laohu8.com/highlight/detail?id=2622273158","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622273158?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 21:45","pubTimestamp":1774619148,"startTime":"0","endTime":"0","summary":"慢性阻塞性肺病是一种慢性疾病，会导致气流受限和呼吸困难。竞争对手的治疗效果参差不齐阿斯利康公司说，它的药物有可能减轻炎症反应，破坏可能导致慢性阻塞性肺病恶化的粘液功能障碍循环。阿斯利康表示，这两项研究的详细结果将在即将召开的医学会议上公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL4T40F14T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU2089984988.USD","LU2293690082.USD","LU1923622614.USD","LU2108987350.USD","IE00BKPKM643.USD","LU0390134368.USD","LU0011850046.USD","LU1084165304.USD","LU0964806797.USD","LU0047473722.EUR","LU0784384876.USD","LU1291159041.SGD","LU0077335932.USD","LU0203347892.USD","LU0211327993.USD","LU0708994859.HKD","LU1051770623.HKD","LU2133065610.SGD","IE00B2B36J28.USD","LU1323610961.USD","LU2237438978.USD","LU0345777147.USD","LU0963555726.SGD","SG9999001176.SGD","LU1481600234.SGD","LU0310799852.SGD","LU0823416689.USD","LU0949170426.SGD","AZN.UK","LU0738911758.USD","LU0976567544.SGD","LU1989772923.USD","IE0009355771.USD","LU1019634622.SGD","LU0882574055.USD","LU0432979614.USD","LU1917777945.USD","LU1989771016.USD","LU2106854487.HKD","03165","LU1104425308.USD","LU0211328371.USD","LU0047473722.SGD","LU0029864427.USD","LU2293690249.USD","IE00BFTCPJ56.SGD","LU0211326839.USD","LU0823399737.USD","LU1003076772.USD"],"gpt_icon":0},{"id":"1120065420","title":"Dupixent®（Dupilumab）獲日本批准，成為首個治療成人天皰瘡（BP）的靶向藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=1120065420","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120065420?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 14:01","pubTimestamp":1774332107,"startTime":"0","endTime":"0","summary":"Dupixent®（Dupilumab）近日在日本获得监管批准，这是该国首个用于治疗成人天疱疮（BP）的靶向药物。这一里程碑式的批准为患有这种罕见且严重的自身免疫性皮肤病的成年患者提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU0823416689.USD","LU0114720955.EUR","LU0053666078.USD","REGN","LU2362541273.HKD","LU0882574055.USD","LU1917777945.USD","LU2237438978.USD","LU1974910355.USD","BK4585","LU0109394709.USD","LU0289739699.SGD","LU2362541513.USD","LU0823434740.USD","LU2023250504.SGD","LU0320765992.SGD","LU0058720904.USD","BK4588","LU2089984988.USD","LU2106854487.HKD","LU2468319806.SGD","LU0889565916.HKD","BK4139","LU0823434583.USD"],"gpt_icon":0},{"id":"2621089747","title":"Kali Therapeutics 與賽諾菲簽約開發自身免疫療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2621089747","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621089747?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 19:52","pubTimestamp":1774266740,"startTime":"0","endTime":"0","summary":"Kali Therapeutics 与赛诺菲签约开发自身免疫疗法路透3月23日 - Kali Therapeutics公司周一表示，它已与法国制药商赛诺菲SASY.PA达成了一项许可协议 ，开发这家私营公司**的**实验性疗法，用于治疗多种自身免疫性疾病。详情如下：根据协议，赛诺菲将获得 KT501 的全球使用权，这是一种利用 Kali Therapeutics 专有发现和研究平台开发的三特异性抗体。Kali Therapeutics 将获得 1.8 亿美元的前期和近期付款，并有资格获得高达 10.5 亿美元的开发和商业里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4T40B107:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0289739699.SGD","LU0882574055.USD","LU2362540622.SGD","LU0058720904.USD","LU0114720955.EUR","REGN","LU0053666078.USD","LU2362541513.USD","LU0109394709.USD","LU0320765992.SGD","LU2468319806.SGD","LU0889565916.HKD","BK4588","LU0823416689.USD","LU1917777945.USD","LU0823434583.USD","LU0823434740.USD","LU2089984988.USD","LU2106854487.HKD","LU2023250504.SGD","LU2237438978.USD","BK4585","LU2362541273.HKD","LU1974910355.USD"],"gpt_icon":0},{"id":"2621752336","title":"EyePoint 起訴競爭對手 Ocular Therapeutix，稱其虛假宣傳眼科藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2621752336","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621752336?lang=zh_tw&edition=fundamental","pubTime":"2026-03-21 05:22","pubTimestamp":1774041725,"startTime":"0","endTime":"0","summary":"路透3月20日 - EyePoint EYPT.O周五提起诉讼，指控竞争对手Ocular Therapeutix OCUL.O散布有关EyePoint及其主要实验性眼药的虚假或误导性信息。EyePoint 公司称，Ocular Therapeutix 公司发表的声明歪曲了该公司和药物 Duravyu 的临床结果。该公司指控 Ocular Therapeutix 诽谤、商业诋毁和违反马萨诸塞州消费者保护法。该公司还指控 Ocular Therapeutix 干扰了其业务关系。Ocular 没有立即回应路透的置评请求。EyePoint 要求法院命令 Ocular Therapeutix 停止发表上述言论，公开撤回声明，并支付赔偿金和法律费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T4081U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0823416689.USD","LU1974910355.USD","LU0823434583.USD","LU2106854487.HKD","LU0114720955.EUR","LU2023250504.SGD","LU2362541513.USD","LU0053666078.USD","BK4588","REGN","LU0058720904.USD","BK4585","LU2468319806.SGD","BK4139","LU2362541273.HKD","LU2362540622.SGD","LU0882574055.USD","LU0109394709.USD","LU1917777945.USD","BK4007","EYPT","LU0823434740.USD","OCUL","LU2237438978.USD","LU2089984988.USD","LU0289739699.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"1121226589","title":"FDA確認2025年11月19日獲批的Eylea Hd補充申請符合優先審評券兑換標準","url":"https://stock-news.laohu8.com/highlight/detail?id=1121226589","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121226589?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 21:06","pubTimestamp":1773320790,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日裁定，针对再生元制药公司Eylea Hd药品的补充申请——该申请已于2025年11月19日获得批准——完全符合兑换优先审评券的资格条件。这一决定意味着再生元公司可凭借此次获批的补充申请，行使优先审评券赋予的加速审评权益。\n优先审评券制度旨在激励药企研发针对特定疾病的创新疗法，允许企业将券用于其他在研药物的审评流程，从而显著缩短审批时间。Eylea Hd作为再生元旗下的重要眼科治疗产品，此次补充申请的获批及符合兑换标准，不仅强化了该产品的市场地位，也为企业后续产品线的加速推进创造了有利条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0823416689.USD","LU0320765992.SGD","LU2362540622.SGD","LU1917777945.USD","LU0053666078.USD","LU0058720904.USD","LU2362541513.USD","LU0882574055.USD","LU2468319806.SGD","LU2106854487.HKD","BK4588","LU0109394709.USD","LU1974910355.USD","LU0114720955.EUR","LU2023250504.SGD","BK4139","LU0823434583.USD","LU0823434740.USD","LU2089984988.USD","BK4585","LU0289739699.SGD","LU2237438978.USD","LU2362541273.HKD","REGN"],"gpt_icon":0},{"id":"1160965279","title":"FDA批准Eylea Hd治療罕見兒科疾病 兑現優先審評券","url":"https://stock-news.laohu8.com/highlight/detail?id=1160965279","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160965279?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 21:06","pubTimestamp":1773320784,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式批准再生元制药公司（Regeneron Pharmaceuticals）的Eylea Hd用于治疗一种罕见儿科疾病。作为此次批准的一部分，再生元制药公司成功兑现了其持有的优先审评券，该举措旨在加速创新疗法的审评流程。\n此次批准标志着Eylea Hd在罕见儿科疾病治疗领域迈出了重要一步。优先审评券的兑现进一步凸显了该疗法在满足未竟医疗需求方面的潜力，为相关患者群体带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU1917777945.USD","LU0823416689.USD","LU0053666078.USD","LU0823434583.USD","LU0058720904.USD","LU1974910355.USD","LU0889565916.HKD","LU2362540622.SGD","BK4588","LU2089984988.USD","LU0320765992.SGD","LU2106854487.HKD","LU2362541273.HKD","BK4585","LU0109394709.USD","LU2468319806.SGD","LU2237438978.USD","REGN","BK4139","LU0289739699.SGD","LU2023250504.SGD","LU0882574055.USD","LU0114720955.EUR","LU0823434740.USD"],"gpt_icon":0},{"id":"2618157119","title":"FDA 連發多份 CRL，開年大批新藥上市申請已遭拒","url":"https://stock-news.laohu8.com/highlight/detail?id=2618157119","media":"制药网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618157119?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 14:39","pubTimestamp":1773211194,"startTime":"0","endTime":"0","summary":"2026年以来，全球医药企业就遭遇了FDA的CRL风暴。2月14日消息，Disc Medicine备受瞩目的候选药物Bitopertin用于治疗罕见血液病红细胞生成性卟啉症的上市申请遭到FDA拒绝。2月3日，阿斯利康公告称，美国FDA就Saphnelo用于成人系统性红斑狼疮患者皮下给药的生物制品许可申请发出完整答复函，驳回了其狼疮治疗药物的自行注射剂型上市申请。总的来说，2026 年 开年以来，已有众多新药上市申请被拒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311144149a6b747a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311144149a6b747a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVOH","LU1093756168.USD","BK4121","INCY","IE00BFMHRM44.USD","BK4585","LU1815336091.USD","BK4530","BK4588","LU0128526141.USD","NVO","LU0390134368.USD","LU0154236417.USD","AZN","BK4007","BK4599","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVOX","BK4532","IE00BKVL7J92.USD","LU0029874061.USD","LU0757428866.USD","REGN"],"gpt_icon":0},{"id":"2618571671","title":"BUZZ-Regeneron 公布減肥藥試驗數據利好後股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2618571671","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618571671?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 03:40","pubTimestamp":1773085249,"startTime":"0","endTime":"0","summary":"BUZZ-Regeneron 公布减肥药试验数据利好后股价上涨3月9日 - ** Regeneron REGN.O股价上涨约2%至774.29美元，此前该公司宣布了一种潜在减肥药物的积极试验结果。** 汉素拥有奥拉多巴肽在大中华区的开发权和商业化权，而Regeneron拥有其他地区的开发权和商业化权。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4T3ZX1VM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU1917777945.USD","03692","LU2362541513.USD","LU0823416689.USD","LU0889565916.HKD","BK4588","LU2023250504.SGD","LU2468319806.SGD","BK1191","LU0058720904.USD","LU0320765992.SGD","LU0053666078.USD","LU0289739699.SGD","LU0882574055.USD","BK1589","LU1974910355.USD","LU0823434740.USD","LU2362541273.HKD","LU2089984988.USD","REGN","BK1583","LU2106854487.HKD","LU0114720955.EUR","BK4139","LU2237438978.USD","LU2362540622.SGD","LU0823434583.USD","BK4585"],"gpt_icon":0},{"id":"1173776344","title":"再生元授權肥胖治療藥物Olatorepatide在中國患者中展現積極三期臨床結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1173776344","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173776344?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 19:05","pubTimestamp":1773054309,"startTime":"0","endTime":"0","summary":"再生元制药公司授权的肥胖治疗药物Olatorepatide，近日在中国患者群体中完成的三期临床试验显示出积极疗效。该研究结果标志着这一创新疗法在亚洲人群中的临床应用取得重要进展，为肥胖症治疗领域注入新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","BK4588","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","LU2106854487.HKD","REGN","LU2362540622.SGD","LU1974910355.USD","LU0823434583.USD","LU0114720955.EUR","LU2023250504.SGD","LU0058720904.USD","LU2468319806.SGD","LU0889565916.HKD","LU1917777945.USD","LU2089984988.USD","BK4585","LU0289739699.SGD","LU2362541273.HKD","LU2237438978.USD","LU0823434740.USD"],"gpt_icon":0},{"id":"1120176878","title":"再生元製藥公司：Olatorepatide治療患者在48周內實現高達19%的體重減輕","url":"https://stock-news.laohu8.com/highlight/detail?id=1120176878","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120176878?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 19:03","pubTimestamp":1773054229,"startTime":"0","endTime":"0","summary":"再生元制药公司公布的最新数据显示，接受Olatorepatide治疗的患者在第48周时体重减轻幅度最高达到19%。这一结果凸显了该药物在体重管理领域的显著疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0823434583.USD","LU1974910355.USD","LU0882574055.USD","BK4585","LU0823416689.USD","LU0058720904.USD","BK4139","LU2362541513.USD","REGN","LU2362541273.HKD","LU0889565916.HKD","LU2023250504.SGD","LU0823434740.USD","LU2089984988.USD","LU0320765992.SGD","LU0053666078.USD","LU2362540622.SGD","LU0109394709.USD","LU0289739699.SGD","LU2237438978.USD","BK4588","LU1917777945.USD","LU2106854487.HKD","LU0114720955.EUR"],"gpt_icon":0},{"id":"1148298032","title":"再生元製藥公司計劃今年晚些時候啓動Olatorepatide全球三期註冊項目","url":"https://stock-news.laohu8.com/highlight/detail?id=1148298032","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148298032?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 19:02","pubTimestamp":1773054148,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，将于今年晚些时候正式启动其候选药物Olatorepatide的全球三期注册临床试验项目。这一关键性研究旨在评估该药物在目标适应症中的疗效与安全性，标志着Olatorepatide的研发进程迈入商业化前的最终阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU0114720955.EUR","LU0109394709.USD","LU2362541273.HKD","BK4588","LU2023250504.SGD","LU0289739699.SGD","LU2106854487.HKD","LU1974910355.USD","LU0320765992.SGD","LU2362541513.USD","BK4585","REGN","LU0053666078.USD","LU0823434583.USD","LU0882574055.USD","LU0889565916.HKD","LU2468319806.SGD","LU2089984988.USD","LU0058720904.USD","LU1917777945.USD","LU2237438978.USD","LU0823416689.USD","LU0823434740.USD","BK4139"],"gpt_icon":0},{"id":"1197814779","title":"再生元製藥公司：Olatorepatide展現良好胃腸道耐受性，不良事件發生率更低","url":"https://stock-news.laohu8.com/highlight/detail?id=1197814779","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197814779?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 19:01","pubTimestamp":1773054106,"startTime":"0","endTime":"0","summary":"再生元制药公司近日公布的研究数据显示，其研发的Olatorepatide在临床试验中表现出优异的胃肠道耐受特性，且不良事件发生率显著低于预期。\n该药物在安全性方面的积极结果为其后续开发奠定了良好基础，有望为相关疾病治疗提供新的选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0823416689.USD","LU0320765992.SGD","LU2362540622.SGD","LU1917777945.USD","LU0053666078.USD","LU0058720904.USD","LU2362541513.USD","LU0882574055.USD","LU2468319806.SGD","LU2106854487.HKD","BK4588","LU0109394709.USD","LU1974910355.USD","LU0114720955.EUR","LU2023250504.SGD","BK4139","LU0823434583.USD","LU0823434740.USD","LU2089984988.USD","BK4585","LU0289739699.SGD","LU2237438978.USD","LU2362541273.HKD","REGN"],"gpt_icon":0},{"id":"1194637037","title":"再生元高管預期將肥胖症藥物定價合理貼近無降膽固醇功效療法水平——TD Cowen會議透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1194637037","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194637037?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 22:43","pubTimestamp":1772635437,"startTime":"0","endTime":"0","summary":"在TD Cowen会议上，再生元制药公司高管表示，公司计划将其肥胖症药物的定价设定在合理范围内，与那些不具备降低胆固醇功效的疗法保持相近水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0109394709.USD","LU0114720955.EUR","LU0882574055.USD","LU0053666078.USD","REGN","LU0889565916.HKD","LU1917777945.USD","LU2089984988.USD","LU2468319806.SGD","LU2023250504.SGD","LU0320765992.SGD","LU2362541273.HKD","BK4588","BK4139","LU2362540622.SGD","BK4585","LU0823434740.USD","LU0823434583.USD","LU1974910355.USD","LU0823416689.USD","LU2362541513.USD","LU2237438978.USD","LU0289739699.SGD","LU2106854487.HKD"],"gpt_icon":0},{"id":"1105620090","title":"再生元製藥公司獲CHMP建議：擴展Dupixent適用年齡至2-11歲中重度CSU患兒","url":"https://stock-news.laohu8.com/highlight/detail?id=1105620090","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105620090?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 20:05","pubTimestamp":1772193938,"startTime":"0","endTime":"0","summary":"再生元制药公司近日迎来重要监管进展——欧洲药品管理局人用医药产品委员会已正式建议批准其与赛诺菲联合开发的Dupixent扩大适应症范围，覆盖2至11岁患有中重度慢性自发性荨麻疹的儿童患者群体。若最终获欧盟委员会批准，Dupixent将成为欧洲首个可用于低龄CSU患儿的靶向生物制剂。再生元与赛诺菲计划继续与全球监管机构密切沟通，推动Dupixent在儿科CSU治疗领域的应用拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU1917777945.USD","LU2362541513.USD","LU0823416689.USD","LU0889565916.HKD","BK4588","LU2023250504.SGD","LU2468319806.SGD","LU0058720904.USD","LU0320765992.SGD","LU0823434583.USD","LU0053666078.USD","LU0289739699.SGD","LU0882574055.USD","LU1974910355.USD","LU2362541273.HKD","LU0823434740.USD","LU2089984988.USD","REGN","LU2237438978.USD","LU0114720955.EUR","BK4139","LU2362540622.SGD","LU2106854487.HKD","BK4585"],"gpt_icon":0},{"id":"1129492584","title":"歐盟建議批准Dupixent®（度普利尤單抗）用於治療持續性症狀的幼童慢性自發性蕁麻疹","url":"https://stock-news.laohu8.com/highlight/detail?id=1129492584","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129492584?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 20:01","pubTimestamp":1772193690,"startTime":"0","endTime":"0","summary":"再生元制药公司研发的Dupixent®（度普利尤单抗）获得欧盟人用药品委员会积极意见，建议批准用于治疗现有疗法控制不佳的6至11岁慢性自发性荨麻疹患儿。该推荐基于III期临床试验数据，显示度普利尤单抗能显著减轻瘙痒和风团症状。若获欧盟委员会最终批准，这将是首个用于低龄儿童群体的慢性自发性荨麻疹靶向疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2106854487.HKD","LU0058720904.USD","LU0823416689.USD","LU1917777945.USD","BK4588","LU0320765992.SGD","LU0823434740.USD","LU2237438978.USD","LU2362541513.USD","LU0289739699.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0109394709.USD","LU1974910355.USD","LU0882574055.USD","BK4139","LU2362540622.SGD","LU0823434583.USD","REGN","BK4585","LU2023250504.SGD","LU0053666078.USD","LU2362541273.HKD","LU0889565916.HKD"],"gpt_icon":0},{"id":"1145911158","title":"歐盟CHMP建議擴大Dupixent（Dupilumab）適用範圍：用於治療2至11歲兒童慢性自發性蕁麻疹","url":"https://stock-news.laohu8.com/highlight/detail?id=1145911158","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145911158?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 18:56","pubTimestamp":1772189798,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用医药产品委员会（CHMP）近日提出重要建议，支持将Dupixent（dupilumab）的治疗范围扩展至2至11岁儿童群体的慢性自发性荨麻疹。这一突破性进展意味着该药物有望为更广泛的患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0882574055.USD","BK4588","LU2106854487.HKD","LU2362541273.HKD","LU0058720904.USD","LU2362541513.USD","LU0289739699.SGD","LU2089984988.USD","LU2237438978.USD","LU1974910355.USD","LU0823434740.USD","LU0320765992.SGD","LU0823434583.USD","REGN","LU2023250504.SGD","LU2362540622.SGD","BK4139","LU0889565916.HKD","LU2468319806.SGD","LU0823416689.USD","LU1917777945.USD","BK4585","LU0109394709.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"1153462180","title":"賽諾菲新適應症獲批 鼻科疾病版圖再拓展：新增過敏性真菌性鼻竇炎 與伴鼻息肉慢性鼻竇炎形成互補","url":"https://stock-news.laohu8.com/highlight/detail?id=1153462180","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153462180?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 22:35","pubTimestamp":1771943715,"startTime":"0","endTime":"0","summary":"赛诺菲宣布其鼻科疾病治疗领域迎来重要突破——新适应症获得监管批准，使得公司现有治疗范围扩展至过敏性真菌性鼻窦炎（AFRS）。此次获批标志着赛诺菲在鼻科疾病领域的治疗版图实现战略性延伸，与已获批的伴鼻息肉慢性鼻窦炎（CRSwNP）适应症形成协同效应。\n新适应症的纳入不仅丰富了赛诺菲在呼吸道疾病领域的管线布局，更凸显了公司针对复杂鼻科炎症疾病的综合解决方案能力。这一进展将有望为更广泛的患者群体提供新的治疗选择，进一步巩固企业在专科治疗领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","BK4588","LU0058720904.USD","LU1974910355.USD","LU2023250504.SGD","LU0114720955.EUR","LU2362541513.USD","LU0882574055.USD","LU0889565916.HKD","LU0823434740.USD","LU2362540622.SGD","BK4585","LU0109394709.USD","LU0289739699.SGD","BK4139","LU2237438978.USD","LU2362541273.HKD","REGN","LU2468319806.SGD","LU0823434583.USD","LU2106854487.HKD","LU0823416689.USD","LU0320765992.SGD","LU1917777945.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"1185013122","title":"賽諾菲與再生元Dupixent獲美國FDA批准 成為首個且唯一用於過敏性真菌性鼻竇炎藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=1185013122","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185013122?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 22:31","pubTimestamp":1771943472,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式批准赛诺菲与再生元制药公司联合开发的Dupixent（度普利尤单抗）用于治疗过敏性真菌性鼻窦炎。该药物由此成为美国境内首个且唯一获批针对此适应症的疗法。\n此次批准为受该慢性疾病困扰的患者提供了新的治疗选择。临床数据显示，Dupixent能显著改善患者症状，凸显其在鼻窦炎治疗领域的突破性意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0289739699.SGD","LU0882574055.USD","LU2362540622.SGD","LU0058720904.USD","LU0114720955.EUR","REGN","LU0053666078.USD","LU2362541513.USD","LU0109394709.USD","LU0320765992.SGD","LU2468319806.SGD","LU0889565916.HKD","BK4588","LU0823416689.USD","LU1917777945.USD","LU0823434583.USD","LU0823434740.USD","LU2089984988.USD","LU2106854487.HKD","LU2023250504.SGD","LU2237438978.USD","BK4585","LU2362541273.HKD","LU1974910355.USD"],"gpt_icon":0},{"id":"1185973301","title":"再生元製藥garetosmab生物製劑許可申請獲FDA優先審評資格","url":"https://stock-news.laohu8.com/highlight/detail?id=1185973301","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185973301?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 20:18","pubTimestamp":1771503531,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，其治疗进行性骨化性纤维发育不良（FOP）的药物garetosmab的生物制剂许可申请已获得美国食品药品监督管理局（FDA）的优先审评资格。\nFDA预计将于2026年8月前做出最终审批决定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","REGN","LU0053666078.USD","LU1974910355.USD","LU2237438978.USD","LU0114720955.EUR","LU0889565916.HKD","LU2362541273.HKD","LU2362540622.SGD","LU2362541513.USD","LU2106854487.HKD","LU0823434583.USD","LU0882574055.USD","LU1917777945.USD","LU2023250504.SGD","BK4585","LU0823434740.USD","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU0823416689.USD","BK4588","BK4139","LU2468319806.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"1139723161","title":"再生元Garetosmab生物製劑許可申請獲FDA優先審評資格 用於治療進行性骨化性纖維發育不良(FOP)","url":"https://stock-news.laohu8.com/highlight/detail?id=1139723161","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139723161?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 20:01","pubTimestamp":1771502480,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，其针对进行性骨化性纤维发育不良（FOP）治疗的Garetosmab生物制剂许可申请（BLA）已获美国食品药品监督管理局（FDA）受理，并被授予优先审评资格。这一重要监管进展有望加速该创新疗法的审评进程，为FOP患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU0823416689.USD","LU0114720955.EUR","LU0053666078.USD","REGN","LU2362541273.HKD","LU0882574055.USD","LU1917777945.USD","LU2237438978.USD","LU1974910355.USD","BK4585","LU0109394709.USD","LU0289739699.SGD","LU2362541513.USD","LU0823434740.USD","LU2023250504.SGD","LU0320765992.SGD","LU0058720904.USD","BK4588","LU2089984988.USD","LU2106854487.HKD","LU2468319806.SGD","LU0889565916.HKD","BK4139","LU0823434583.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}]}}